Table 4.
Inter-person variability between three investigators was evaluated. Each investigator prepared three curves, and a curve was made from the average of the data for each person for comparison. Each standard was assayed in triplicate.
Hypothetical Sample (A565) | Investigator 1 | Investigator 2 | Investigator 3 | Ave | St Dev | CV | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Trial 1 | Trial 2 | Trial 3 | Trial 1 | Trial 2 | Trial 3 | Trial 1 | Trial 2 | Trial 3 | ||||
0.10 | 9.61 | 8.11 | 5.63 | 6.36 | 7.23 | 4.23 | 1.57 | NA | NA | 6.11 | 2.64 | 0.43 |
0.20 | 68.44 | 66.21 | 68.82 | 69.51 | 68.96 | 76.14 | 52.38 | 38.56 | 47.32 | 61.82 | 7.23 | 0.12 |
0.30 | 129.25 | 126.90 | 133.06 | 131.49 | 130.86 | 148.56 | 104.99 | 79.73 | 97.21 | 120.23 | 12.84 | 0.11 |
0.20 | 192.24 | 190.55 | 198.41 | 192.36 | 192.92 | 221.48 | 159.61 | 122.02 | 148.33 | 179.77 | 18.08 | 0.10 |
0.50 | 257.66 | 257.66 | 264.93 | 252.18 | 255.14 | 294.93 | 216.49 | 165.54 | 200.77 | 240.59 | 22.99 | 0.10 |
0.60 | 325.84 | 328.85 | 332.67 | 311.00 | 317.53 | 368.91 | 275.94 | 210.40 | 254.63 | 302.86 | 27.79 | 0.09 |
0.70 | 397.13 | 404.97 | 401.72 | 368.87 | 380.09 | 443.44 | 338.35 | 256.73 | 310.05 | 366.82 | 32.86 | 0.09 |
0.80 | 472.02 | 487.21 | 472.14 | 425.83 | 442.81 | 518.53 | 404.20 | 304.69 | 367.16 | 432.73 | 38.80 | 0.09 |